Key Points
- Intuitive Surgical EVP Mark Brosius sold 77 shares at an average price of $390.67, totaling $30,081.59. The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, leaving him with 1,189 shares.
- Intuitive Surgical reported strong quarterly results, with earnings of $2.80 per share and revenue of $2.89 billion, exceeding analyst expectations. Revenue increased 18.4% year over year.
- Wall Street maintains a generally positive view, with a consensus “Moderate Buy” rating and an average price target of $508.68; institutional investors own 83.64% of the company.
Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) EVP Mark Brosius sold 77 shares of the firm's stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $390.67, for a total value of $30,081.59. Following the completion of the transaction, the executive vice president directly owned 1,189 shares in the company, valued at $464,506.63. The trade was a 6.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Mark Brosius also recently made the following trade(s):
- On Wednesday, August 19th, Mark Brosius sold 77 shares of Intuitive Surgical stock. The stock was sold at an average price of $394.26, for a total transaction of $30,358.02.
- On Friday, July 31st, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $351.00, for a total transaction of $9,828.00.
- On Wednesday, July 29th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $360.21, for a total value of $10,085.88.
- On Monday, July 27th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $344.00, for a total value of $9,632.00.
- On Friday, June 12th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The stock was sold at an average price of $414.13, for a total value of $10,353.25.
- On Wednesday, June 10th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The shares were sold at an average price of $424.14, for a total value of $9,755.22.
- On Monday, June 8th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The shares were sold at an average price of $420.12, for a total transaction of $9,662.76.
- On Friday, May 22nd, Mark Brosius sold 18 shares of Intuitive Surgical stock. The stock was sold at an average price of $439.80, for a total transaction of $7,916.40.
Intuitive Surgical Stock Up 1.7%
ISRG stock opened at $397.72 on Thursday. The business's 50-day simple moving average is $389.89 and its 200 day simple moving average is $438.02. The company has a market cap of $140.51 billion, a PE ratio of 45.56, a price-to-earnings-growth ratio of 2.83 and a beta of 1.46. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.48 by $0.32. The business had revenue of $2.89 billion for the quarter, compared to analysts' expectations of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.Intuitive Surgical's quarterly revenue was up 18.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.81 earnings per share. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.
Institutional Investors Weigh In On Intuitive Surgical
Institutional investors and hedge funds have recently made changes to their positions in the company. Norges Bank acquired a new stake in Intuitive Surgical during the 4th quarter worth $2,856,987,000. Bank of New York Mellon Corp bought a new position in shares of Intuitive Surgical in the 2nd quarter worth $1,335,753,000. J. Stern & Co. LLP grew its stake in shares of Intuitive Surgical by 18,504.6% during the fourth quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider's stock worth $1,204,788,000 after purchasing an additional 2,115,814 shares during the period. Northwestern Mutual Wealth Management Co. increased its holdings in Intuitive Surgical by 1,043.3% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider's stock valued at $760,124,000 after purchasing an additional 1,224,734 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its stake in Intuitive Surgical by 95.3% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider's stock valued at $970,635,000 after buying an additional 1,027,475 shares during the period. Institutional investors own 83.64% of the company's stock.
Wall Street Analysts Forecast Growth
Several analysts recently commented on ISRG shares. Sanford C. Bernstein reaffirmed an "outperform" rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Bank of America dropped their target price on shares of Intuitive Surgical from $520.00 to $515.00 in a research report on Friday, June 12th. Mizuho set a $500.00 price target on shares of Intuitive Surgical and gave the company a "neutral" rating in a report on Wednesday, July 15th. Oppenheimer raised shares of Intuitive Surgical from a "market perform" rating to an "outperform" rating and set a $500.00 price objective for the company in a report on Wednesday, August 12th. Finally, Citigroup reduced their target price on Intuitive Surgical from $590.00 to $500.00 and set a "buy" rating on the stock in a report on Friday, July 17th. Twenty-two research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $508.68.
View Our Latest Research Report on ISRG
About Intuitive Surgical
(
Get Free Report)
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
